Tick Collar

Verify with FDA CVM →

47 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
47
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Tick Collar

Administration Routes

UnknownTopicalCutaneousOther

Species Affected

Dog 46
Unknown 1

Most Affected Breeds

Crossbred Canine/dog 4
Retriever - Labrador 4
Boxer (German Boxer) 4
Dog (unknown) 4
Beagle 3
Retriever - Golden 3
Terrier - Silky 2
Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 2
Retriever (unspecified) 2
Shepherd Dog - Australian 2

Most Reported Reactions

Emesis 20
Lethargy (see also Central nervous system depression in 'Neurological') 7
Lack of efficacy (ectoparasite) - flea 6
Scratching 4
Lack of efficacy - NOS 4
Crying 3
Head shake - ear disorder 3
Shaking 3
Seizure NOS 3
Vomiting 3
Behavioural disorder NOS 2
Not sleeping 2

Outcome Breakdown

Recovered/Normal
33 (71.7%)
Outcome Unknown
11 (23.9%)
Recovered with Sequela
2 (4.3%)

Data Summary

Metric Value
Total adverse event reports 47
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Tick Collar Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 47 adverse event reports referencing Tick Collar, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Tick Collar. Reported administration routes include Unknown, Topical, Cutaneous, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Tick Collar reports are Dog (46 reports), Unknown (1 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (4), Retriever - Labrador (4), Boxer (German Boxer) (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Tick Collar are Emesis (20), Lethargy (see also Central nervous system depression in 'Neurological') (7), Lack of efficacy (ectoparasite) - flea (6), Scratching (4). Of the 46 reports with a coded outcome, Recovered/Normal is the leading category at 71.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Tick Collar.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial